Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Clinical trial NCT02297490 · TERMINATED

Trial details

NCT number: NCT02297490
Sponsor: Allergopharma GmbH & Co. KG
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis Healthy Volunteers

Start date: 2014-01-01
Primary completion: 2014-11-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.